Bardy Diagnostics™ Selected as One of Six Disruptive MedTech Startups For the HealthTech Arkansas Accelerator Program |
| August 09, 2019 | August 2019 Bond Updates |
|
SEATTLE, Aug. 9, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that HealthTech Arkansas, a healthcare accelerator and investment fund that connects early-stage healthcare... |
| View more at: https://www.prnewswire.com:443/news-releases/bardy-diagnostics-selected-as-one-of-six-disruptive-medtech-startups-for-the-healthtech-arkansas-accelerator-program-300899157.html |